ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference GlobeNewswire October 29, 2025 WINSTON-SALEM, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members […]

Coppernico Metals Expands Concessions at Sombrero GlobeNewswire October 29, 2025 VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) — Coppernico Metals Inc. (TSX: COPR, OTCQB: CPPMF, FSE: 9I3) (“Coppernico” or the “Company”), is pleased to announce that, through its wholly owned private Peruvian subsidiary, Sombrero Minerales SAC, it has expanded its concessions through an application

Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT(TM) in Patients with Gorlin Syndrome Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetime

Magna Ramps Up Driver and Occupant Monitoring System Deployment in China with Germany-Based OEM GlobeNewswire October 29, 2025 Magna expands global partnership with growing DMS volumes in China and Europe Following initial SOP in 2024, Magna's DMS is now entering its first full year of scaled global production First-to-market, scalable DMS supports China's automotive innovation

First American Uranium Discovers New Pegmatite Outcrop During Site Visit; Confirms 27 km of Prospective Nb-REE Trends at Seigneurie, Quebec GlobeNewswire October 29, 2025 Vancouver, BC, Oct. 29, 2025 (GLOBE NEWSWIRE) — First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (“First American Uranium”, or the “Company”) is pleased to announce the successful completion

Vireo Growth Inc. and Verano Holdings Corp. Announce Resolution of Litigation Matters GlobeNewswire October 29, 2025 CHICAGO and MINNEAPOLIS, Oct. 29, 2025 (GLOBE NEWSWIRE) — Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) and Verano Holdings Corp. (“Verano”, Vireo and Verano, each a “Company”) (Cboe CA: VRNO) (OTCQX: VRNOF) today announced that they have reached

Watsco Reports Record Third Quarter Gross Profit, Gross Margin and Operating Cash Flow in Challenging Market Conditions Strong Balance Sheet and Market-Leading Technologies Enable Continued Investments in Growth GlobeNewswire October 29, 2025 MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced its operating results for the third quarter and nine-month period ended

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th GlobeNewswire October 29, 2025 BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November

Amerigo Announces Q3-2025 Results, Full Debt Repayment and Quarterly Dividend Increase GlobeNewswire October 29, 2025 Q3-2025 Net Income of $6.7 million, EBITDA1 of $18.7 million and Free Cash Flow to Equity1 of $11.1 million Full Debt Repayment Achieved in October 2025 Quarterly dividend Increased by 33% Quarterly Dividend of Cdn$0.04 Declared VANCOUVER, British Columbia, Oct.

Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Control Group GlobeNewswire October 29, 2025 ADAS-Cog13 difference âˆ'12.78 (P < 0.0001) with oral blarcamesine treatment compared to ADNI control group at Week 144 77.4 Weeks (17.8 Months) 'time saved' with oral blarcamesine compared